PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
6863481-8	1983	Thus, an unusual case of hypoparathyroidism after I-131 therapy with return of parathyroid function is documented by measurements of both immunoreactive and bioactive PTH.	Iodine-131	50-55	parathyroid hormone	Homo sapiens	167-170	
15943755-5	2005	Radioiodine in doses used for benign thyroid diseases appears safe with regard to parathyroid hormone and calcitonin secretion.	Iodine-131	0-11	parathyroid hormone	Homo sapiens	82-101	
14715479-6	2003	After thyroid ablation with 131I, the serum calcium and thyroxine levels decreased, and the parathyroid hormone and 1,25-dihydroxyvitamin D3 levels normalized.	Iodine-131	28-32	parathyroid hormone	Homo sapiens	92-111	
2723030-7	1989	Serum PTH rose along with TSH as the patients became hypothyroid after radioiodine, and both serum PTH and TSH fell when L-T4 therapy was given.	Iodine-131	71-82	parathyroid hormone	Homo sapiens	6-9	
10585001-0	1999	PTH decrease after radioiodine treatment in a patient with end-stage renal disease.	Iodine-131	19-30	parathyroid hormone	Homo sapiens	0-3	
1822999-0	1991	Parathyroid hormone secretory reserve in patients submitted to 131-iodine therapy for hyperthyroidism.	Iodine-131	63-73	parathyroid hormone	Homo sapiens	0-19	
2723030-0	1989	Reciprocal changes in parathyroid hormone and thyroid function after radioiodine treatment of hyperthyroidism.	Iodine-131	69-80	parathyroid hormone	Homo sapiens	22-41	
2723030-3	1989	In this study, we measured serum PTH concentrations using a newly developed sensitive 2-site immunoradiometric assay in 17 hyperthyroid patients before and after radioiodine therapy.	Iodine-131	162-173	parathyroid hormone	Homo sapiens	33-36	
33715818-0	2021	Parathyroid Hormone Level Changes Following Radioiodine Therapy for Thyroid Cancer: A Prospective Observational Study.	Iodine-131	44-55	parathyroid hormone	Homo sapiens	0-19	
33715818-1	2021	OBJECTIVE: Our objective was to analyze the effect of radioiodine (RAI) therapy on parathyroid hormone (PTH) secretion.	Iodine-131	54-65	parathyroid hormone	Homo sapiens	83-102	
33715818-1	2021	OBJECTIVE: Our objective was to analyze the effect of radioiodine (RAI) therapy on parathyroid hormone (PTH) secretion.	Iodine-131	54-65	parathyroid hormone	Homo sapiens	104-107	
33715818-1	2021	OBJECTIVE: Our objective was to analyze the effect of radioiodine (RAI) therapy on parathyroid hormone (PTH) secretion.	Iodine-131	67-70	parathyroid hormone	Homo sapiens	83-102	
33715818-1	2021	OBJECTIVE: Our objective was to analyze the effect of radioiodine (RAI) therapy on parathyroid hormone (PTH) secretion.	Iodine-131	67-70	parathyroid hormone	Homo sapiens	104-107	
33715818-8	2021	CONCLUSION: RAI therapy had a significant transient adverse effect on parathyroid gland function in patients with decreased PTH secretion pretherapy, and the extent was associated with the amount of residual thyroid tissue.	Iodine-131	12-15	parathyroid hormone	Homo sapiens	124-127